Holen Sie sich die Stockscreener-App
113.96
5.56%
6.57
Schlusskurs vom Vortag:
$107.39
Offen:
$120
24-Stunden-Volumen:
3.32M
Relative Volume:
1.26
Marktkapitalisierung:
$21.94B
Einnahmen:
$29.52M
Nettoeinkommen (Verlust:
$-567.06M
KGV:
-31.14
EPS:
-3.66
Netto-Cashflow:
$-551.11M
1W Leistung:
+43.46%
1M Leistung:
+45.69%
6M Leistung:
+194.29%
1J Leistung:
+155.20%
1-Tages-Spanne:
$111.50
$120.49
1-Wochen-Bereich:
$76.28
$120.49
52-Wochen-Spanne:
$29.17
$120.49
Revolution Medicines Inc Stock (RVMD) Company Profile
Firmenname
Revolution Medicines Inc
Sektor
Branche
Telefon
415-766-3638
Adresse
700 SAGINAW DR, REDWOOD CITY, CA
Vergleichen Sie RVMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RVMD
Revolution Medicines Inc
|
113.50 | 20.76B | 29.52M | -567.06M | -551.11M | -3.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
473.96 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
818.57 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
408.25 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
811.40 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
338.41 | 35.45B | 4.98B | 69.59M | 525.67M | 0.5197 |
Revolution Medicines Inc Stock (RVMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-18 | Eingeleitet | Wolfe Research | Outperform |
| 2025-11-03 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-10-21 | Eingeleitet | Mizuho | Outperform |
| 2025-10-16 | Fortgesetzt | Stifel | Buy |
| 2025-09-12 | Fortgesetzt | Raymond James | Strong Buy |
| 2025-09-05 | Eingeleitet | Truist | Buy |
| 2025-08-19 | Eingeleitet | Piper Sandler | Overweight |
| 2025-08-15 | Eingeleitet | Wells Fargo | Overweight |
| 2025-07-15 | Eingeleitet | Goldman | Buy |
| 2024-07-16 | Bestätigt | Needham | Buy |
| 2024-07-12 | Eingeleitet | Barclays | Overweight |
| 2024-07-08 | Eingeleitet | Jefferies | Buy |
| 2024-04-12 | Bestätigt | Needham | Buy |
| 2024-04-10 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-03-11 | Eingeleitet | Piper Sandler | Overweight |
| 2024-01-05 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-01-04 | Eingeleitet | Wedbush | Outperform |
| 2023-11-16 | Eingeleitet | Raymond James | Outperform |
| 2023-02-28 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-12-14 | Eingeleitet | Needham | Buy |
| 2022-10-21 | Eingeleitet | Oppenheimer | Outperform |
| 2022-05-20 | Eingeleitet | BofA Securities | Neutral |
| 2022-03-01 | Hochstufung | Stifel | Hold → Buy |
| 2021-09-23 | Eingeleitet | Stifel | Hold |
| 2021-08-12 | Herabstufung | Goldman | Buy → Neutral |
| 2021-05-18 | Eingeleitet | Goldman | Buy |
| 2020-05-21 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-03-09 | Eingeleitet | Cowen | Outperform |
| 2020-03-09 | Eingeleitet | Guggenheim | Buy |
| 2020-03-09 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Revolution Medicines Inc Aktie (RVMD) Neueste Nachrichten
Wedbush lifts Revolution Medicines PT as Merck takeover talks heat up - TradingView — Track All Markets
Stock Movers: Meta, Revolution Medicines, GM - Bloomberg.com
Speculation builds about a multibillion-dollar takeout of Revolution Medicines - Endpoints News
Merck in Talks to Buy Biotech Revolution Medicines, FT Says - Bloomberg.com
M&A News: Revolution Medicines (RVMD) Stock Rallies on News of Potential Acquisition by Merck - TipRanks
Rocket Cos., Opendoor, GM, Apple, Glencore, Revolution Medicines, Tilray, and More Movers - Barron's
Report says MSD is in talks to buy Revolution Meds - pharmaphorum
Merck in talks to buy Revolution Medicines, shares jump 16% By Investing.com - Investing.com Australia
Merck in talks to buy Revolution Medicines, shares jump 16% - Investing.com
Revolution Medicines stock soars on report of AbbVie takeover - MSN
Merck reportedly consiering a major acquisition (Revolution Medicines) - MarketScreener
Merck in Talks to Acquire Revolution Medicines in USD 28-32 Billion Oncology Deal - Medical Dialogues
Merck In Talks To Buy Cancer Drug-Maker Revolution Medicines In A $28 To $32 Billion Deal — Stock Soars Overnight - Benzinga
Merck Reportedly in Talks to Buy Revolution in Up to $32 Billion Deal - MarketScreener
Revolution Medicines Stock Pre-Market (+15%) : FDA Grants Breakthrough Therapy Designation for Zoldonrasib - Trefis
RVMD stock hits a record high on rumored takeover interest - MSN
Revolution Medicines jumps on report AbbVie nears takeover - MSN
Merck Reportedly In Talks to Buy Biotech Firm Revolution Medicines for Up to US$32B - AASTOCKS.com
Is It Too Late To Consider Revolution Medicines (RVMD) After Its Recent Share Price Surge? - simplywall.st
US Stock Movement | Revolution Medicines Surges Over 13% in After-Hours Trading Amid Reports of Acquisition Talks with Merck for Up to $32 Billion - Bitget
FDA grants breakthrough therapy designation to Revolution Medicines’ lung cancer drug - Investing.com Nigeria
Revolution Medicines takeout speculation spotlight shines on Merck & Co. - FirstWord
Merck, not AbbVie, in talks to buy biotech Revolution Medicines, FT says - Crain's Chicago Business
Merck (MRK) Eyes Acquisition of Revolution Medicines (RVMD) - GuruFocus
Revolution Medicines Stock Soars: Time to Buy? - timothysykes.com
Merck in talks to buy biotech Revolution in up to $32 billion deal, FT reports - Reuters
Why Revolution Medicines’ Stock Is Suddenly Under Pressure - TipRanks
Price tag of $28bn to $32bn was being discussed as part of Merck-Revolution Medicines dealFT - MarketScreener
Merck (MRK) Reportedly in Acquisition Discussions with Revolutio - GuruFocus
Merck might buy Revolution Medicines - breakingthenews.net
Merck in talks to buy biotech Revolution Medicines, FT reports By Reuters - Investing.com
Revolution Medicines stock rises on Merck acquisition talks By Investing.com - Investing.com Nigeria
Merck Looks To Buy Cancer Drugmaker Revolution Medicines: Report - Stocktwits
Revolution Medicines stock rises on Merck acquisition talks - Investing.com
Merck in talks to buy biotech Revolution Medicines, FT reports - Yahoo Finance
Merck in Deal Talks With Biotech Revolution Medicines, FT Says - Bloomberg.com
Why Revolution Medicines Inc. Equity Warrant stock remains resilient2025 Bull vs Bear & Proven Capital Preservation Methods - ulpravda.ru
Merck in talks to buy biotech Revolution Medicines, Financial Times reports - TradingView — Track All Markets
Merck in talks to buy cancer drugmaker Revolution Medicines for up to $32bn - Financial Times
Will Revolution Medicines Inc. Equity Warrant stock deliver shareholder value2025 Support & Resistance & Stepwise Swing Trade Plans - ulpravda.ru
AbbVie stock drops after Revolution deal denial, $1.3 billion charge spooks traders - TechStock²
AbbVie Stock Drops After Guidance Update, Wolfe Downgrade And Deal Denial - Benzinga
What's Going With Cancer Biotech Erasca Stock On Thursday? - Benzinga
Investors Purchase Large Volume of Call Options on Revolution Medicines (NASDAQ:RVMD) - MarketBeat
Revolution Medicines (NASDAQ:RVMD) Shares Gap DownTime to Sell? - MarketBeat
What sentiment indicators say about Revolution Medicines Inc. stockDividend Yield Trends & Free Stock Trading Signal Access - bollywoodhelpline.com
AbbVie denies it’s in talks to buy Revolution Medicines. Both stocks are falling. - MSN
Will Revolution Medicines Inc. stock maintain dividend yieldJuly 2025 Decliners & Weekly Top Stock Performers List - ulpravda.ru
Revolution Medicines (RVMD) Gains FDA Breakthrough Status for Ca - GuruFocus
The $20 Billion Question: Revolution Medicines Surges as Big Pharma Circles the Pan-RAS Leader - FinancialContent
RVMD Stock Hits a Record High on Rumored Takeover Interest - The Globe and Mail
Finanzdaten der Revolution Medicines Inc-Aktie (RVMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):